×
For best experience we recommend to activate Javascript in your browser.
F2RL3 antibody (C-Term)
The Rabbit Polyclonal anti-F2RL3 antibody has been validated for WB, ELISA and IHC. It is suitable to detect F2RL3 in samples from Human, Mouse and Rat.
Quick Overview for F2RL3 antibody (C-Term) (ABIN3186327)
Target
See all F2RL3 Antibodies
F2RL3
(Coagulation Factor II (Thrombin) Receptor-Like 3 (F2RL3))
Reactivity
All reactivities for F2RL3 antibodies
Human, Mouse, Rat
Host
All hosts for F2RL3 antibodies
Rabbit
Clonality
All clonalities for F2RL3 antibodies
Polyclonal
Conjugate
All conjugates for F2RL3 antibodies
This F2RL3 antibody is un-conjugated
Application
All applications for F2RL3 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-F2RL3 Antibody
(hide)
Binding Specificity
All epitopes for F2RL3 antibodies
C-Term
Specificity
PAR4 Polyclonal Antibody detects endogenous levels of PAR4 protein.
Characteristics
Rabbit Polyclonal to PAR4.
Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Immunogen
Synthesized peptide derived from the C-terminal region of human PAR4.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
WB 1:500-1:2000, IHC 1:100-1:300, ELISA 1:10000,
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Avoid repeated freeze/thaw cycles.
Storage
-20 °C
Storage Comment
Store at -20°C.
Target Details for F2RL3
(hide)
Target
F2RL3
(Coagulation Factor II (Thrombin) Receptor-Like 3 (F2RL3))
Alternative Name
PAR4
Molecular Weight
45/36 kDa
Gene ID
5074
UniProt
Q96IZ0
Pathways
Carbohydrate Homeostasis , Regulation of Carbohydrate Metabolic Process
Recently viewed
(hide)
Chat with us , powered by LiveChat